Results
|
|
125781.
|
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group. [electronic resource] by
- Schellhammer, P
- Sharifi, R
- Block, N
- Soloway, M
- Venner, P
- Patterson, A L
- Sarosdy, M
- Vogelzang, N
- Jones, J
- Kolvenbag, G
Producer: 19950612
In:
Urology vol. 45
Availability: No items available.
|
|
|
125782.
|
|
|
|
125783.
|
A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenografts. [electronic resource] by
- Wright, P S
- Cross-Doersen, D
- Th'ng, J P
- Guo, X W
- Crissman, H A
- Bradbury, E M
- Montgomery, L R
- Thompson, F Y
- Loudy, D E
- Johnston, J O
- Bitonti, A J
Producer: 19960222
In:
Experimental cell research vol. 222
Availability: No items available.
|
|
|
125784.
|
|
|
|
125785.
|
|
|
|
125786.
|
|
|
|
125787.
|
|
|
|
125788.
|
|
|
|
125789.
|
|
|
|
125790.
|
|
|
|
125791.
|
|
|
|
125792.
|
|
|
|
125793.
|
|
|
|
125794.
|
|
|
|
125795.
|
|
|
|
125796.
|
|
|
|
125797.
|
|
|
|
125798.
|
|
|
|
125799.
|
|
|
|
125800.
|
|